2025-09-06 - Analysis Report
Okay, here's a report summarizing the provided data for Colgate-Palmolive Co. (CL), with analysis and context where appropriate.

**Colgate-Palmolive Co. (CL) Analysis**

Colgate-Palmolive is a global consumer products company focused on the production, distribution, and provision of household, health care, personal care, and veterinary products.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (CL):** 12.92%
*   **Cumulative Return (VOO):** 101.31%
*   **Absolute Divergence:** -88.39%
*   **Relative Divergence:** 3.3 (on a scale of min/max historical divergence)

**Analysis:** CL has significantly underperformed the S&P 500 (VOO) over the period. The relative divergence suggests this underperformance is near the low end of its historical range.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha   | Beta | Cap(B) |
| :----------- | :----- | :----- | :------ | :--- | :----- |
| 2015-2017  | 13.0%  | 4.5%   | -16.0%  | 0.0  | 61.0   |
| 2016-2018  | -11.0% | 65.2%  | -29.0%  | 0.1  | 48.1   |
| 2017-2019  | 7.0%   | 65.2%  | -22.0%  | 0.1  | 55.6   |
| 2018-2020  | 18.0%  | 65.2%  | -2.0%   | 0.6  | 69.1   |
| 2019-2021  | 30.0%  | 58.6%  | -19.0%  | 0.7  | 69.0   |
| 2020-2022  | 7.0%   | 69.0%  | 5.0%    | 0.7  | 63.7   |
| 2021-2023  | 6.0%   | 69.0%  | -12.0%  | 0.8  | 64.4   |
| 2022-2024  | 13.0%  | 69.0%  | -12.0%  | 0.8  | 73.5   |
| 2023-2025  | 0.0%   | 70.6%  | -53.0%  | 0.3  | 68.8   |

**Analysis:**

*   **Alpha:** Mostly negative Alpha values suggest underperformance relative to its risk-adjusted benchmark. More recently the alpha fell quite sharply.
*   **Beta:** Consistently low Beta values (0.0~0.8) indicate lower volatility than the market.
*   **MDD:** Maximum Drawdown is very high, and it means high risk.
*   **CAGR:** Compared to past performance, it fell sharply from 13% to 0%.

**2. Recent Price Action**

*   **Current Price:** 85.13
*   **Previous Close:** 83.67
*   **Change:** 1.74
*   **5-day Moving Average:** 84.02
*   **20-day Moving Average:** 84.736
*   **60-day Moving Average:** 87.2157

**Analysis:** The stock price has recently increased, closing above both its 5-day and 20-day moving averages. However, the price is still below its 60-day moving average, potentially indicating a short-term upward trend within a longer-term downward or sideways trend.

**3. Technical Indicators & Outlook**

*   **MRI (Market Risk Indicator):** 0.3322 (Low Risk)
*   **RSI:** 50.31
*   **PPO:** 0.1081
*   **Hybrid Signal:** Buy 80% of cash (9 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence:** 3.3 (+): Short-term increase.
*   **Expected Return:** -1059.4% (vs. S&P 500, long-term)

**Analysis:**

*   The MRI indicates a low-risk environment.
*   The RSI is neutral, suggesting neither overbought nor oversold conditions.
*   The PPO is slightly positive, indicating a potential upward trend.
*   The Hybrid Signal suggests a cautious buying strategy.
*   The significant recent price change (1.74) indicates some upward momentum and reflects recent issues or events.
*   The extremely negative expected return should be interpreted with caution. It likely reflects the model's assessment based on the historical underperformance relative to the S&P 500 and might not be indicative of future performance.

**4. Recent News & Significant Events**

*   **Exports rise, imports fall: Canada’s trade deficit shrinks (Investing.com):**  While not directly CL-specific, this indicates broader macroeconomic trends.
*   **Trump urges Putin-Zelenskiy meeting (Investing.com):** Geopolitical news that could affect overall market sentiment.
*   **Conditions for stock market rally (Investing.com):** General market analysis relevant to all stocks.
*   **Colgate-Palmolive Stock Performance Compared to Other Consumer Staples (Barchart):** Directly relevant, this should be reviewed for specific insights on CL's relative strength/weakness within its sector.
*   **US oil futures dip (Investing.com):** Another general economic indicator.
*   **Argus Cuts Colgate-Palmolive's Price Target to $100 From $106 (MT Newswires):** Negative analyst sentiment.

**Analysis:** The news is a mixed bag.  The Argus price target cut is a negative signal. The article comparing CL to its peers is crucial for understanding its competitive position.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (~2.10)
*   **Target Price:** 95.22 (Avg) / 106.00 (High) / 83.00 (Low)

**Analysis:** The analyst consensus is "Buy," with a mean rating around 2.10. The average target price suggests potential upside from the current price. However, recent rating changes (even if unspecified) should be investigated for the magnitude and reasons behind those changes.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
| :--------- | :--- | :--------- |
| 2025-08-01 | 0.92 | 5.11 B$    |
| 2025-04-25 | 0.85 | 4.91 B$    |
| 2024-10-25 | 0.9  | 5.03 B$    |
| 2024-07-26 | 0.89 | 5.06 B$    |
| 2025-08-01 | 0.89 | 5.06 B$    |

**Analysis:**  Recent earnings have been relatively stable, with a slight increase in EPS and revenue in the most recent quarter.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue | Profit Margin |
| :--------- | :------ | :------------ |
| 2025-06-30 | $5.11B | 60.06%        |
| 2025-03-31 | $4.91B | 60.82%        |
| 2024-12-31 | $4.95B | 60.30%        |
| 2024-09-30 | $5.03B | 61.08%        |
| 2024-06-30 | $5.06B | 60.62%        |

**Capital and Profitability**

| Quarter    | Equity   | ROE        |
| :--------- | :------- | :--------- |
| 2025-06-30 | $0.70B | 105.84%    |
| 2025-03-31 | $0.36B | 190.08%    |
| 2024-12-31 | $0.21B | 348.58%    |
| 2024-09-30 | $0.43B | 169.43%    |
| 2024-06-30 | $0.12B | 594.31%    |

**Analysis:**

*   **Revenue:** Relatively stable revenue.
*   **Profit Margin:** Consistently high profit margins, indicating strong pricing power and efficient operations.
*   **Equity:** Fluctuating equity values.
*   **ROE:** Extremely high ROE values, particularly in the earlier quarters. These high ROE figures might warrant further investigation to ensure accuracy and understand the underlying drivers (e.g., potential debt leverage).

**7. Overall Summary**

Colgate-Palmolive (CL) is a stable, large-cap company with consistently high profit margins. However, it has significantly underperformed the S&P 500 recently, and its historical Alpha values are primarily negative.  Recent price action suggests a potential short-term upward trend, but the price is still below its 60-day moving average. While analyst consensus is "Buy," a recent price target downgrade from Argus warrants attention. The low MRI suggests a lower risk, but the significantly negative expected return highlights the underperformance against the S&P 500.  The recent earnings and revenue data are stable. High ROE values should be interpreted with caution until the underlying reason is verified.
